Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

  1. Averna, M.
  2. Banach, M.
  3. Bruckert, E.
  4. Drexel, H.
  5. Farnier, M.
  6. Gaita, D.
  7. Magni, P.
  8. März, W.
  9. Masana, L.
  10. Mello e Silva, A.
  11. Reiner, Z.
  12. Ros, E.
  13. Vrablik, M.
  14. Zambon, A.
  15. Zamorano, J.L.
  16. Stock, J.K.
  17. Tokgözoğlu, L.S.
  18. Catapano, A.L.
Aldizkaria:
Atherosclerosis

ISSN: 1879-1484,  0021-9150

Argitalpen urtea: 2021

Alea: 325

Orrialdeak: 99-109

Mota: Oharra

DOI: 10.1016/J.ATHEROSCLEROSIS.2021.03.039 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus